NEW YORK, Oct 12 – Illumina reported Thursday third-quarter net losses of $3.9 million, or 15 cents a share, on a pro forma basis, compared with a net loss of $1.5 million, or 11 cents a share in the year ago period.

Consensus estimates forecast net losses of 20 cents a share, based on two analysts surveyed by First Call/Thomson Financial.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

In Nature this week: a Danish reference genome, and more.